Anemia of critical illness (Q37281589)

19 August 2017

1 reference

title

Anemia of critical illness (English)

1 reference

19 August 2017

Kwame Asare

1

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

28

1 reference

19 August 2017

issue

10

1 reference

19 August 2017

page(s)

1267-1282

1 reference

RBC transfusion in the ICU. Is there a reason?

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Chemotherapy-induced anemia in adults: incidence and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Iron supplementation in the intensive care unit: when, how much, and by what route?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Proteomics and systems biology approaches to signal transduction in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Anemia and blood transfusion in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Phlebotomy for diagnostic laboratory tests in adults. Pattern of use and effect on transfusion requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Phlebotomy in the intensive care unit: strategies for blood conservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Blood loss and replacement in total hip arthroplasty: a multicenter study. The Preoperative Autologous Blood Donation Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Blunted erythropoietic response to anemia in multiply traumatized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Managing anemia in the critically ill patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

The molecular biology of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Diagnosis and management of iron-related anemias in critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Diagnosis and management of iron-deficiency anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Anemia of chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Effect of anaemia and cardiovascular disease on surgical mortality and morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Anemia: not just an innocent bystander?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Nursing strategies to minimize blood loss associated with phlebotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

21 January 2018

Transfusion and surgery

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Determinants of red blood cell transfusions in a pediatric critical care unit: a prospective, descriptive epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

A new formula for blood transfusion volume in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Transfusion strategies for patients in pediatric intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Prudent Strategies for Elective Red Blood Cell Transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Controversies in RBC transfusion in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Pneumonia as a complication of blood product transfusion in the critically ill: transfusion-related immunomodulation (TRIM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Transfusion and the lung: circulatory overload and acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Transfusion and lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

IgA anaphylactic transfusion reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Reports of 355 transfusion-associated deaths: 1976 through 1985.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Clinical consequences of red cell storage in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Microvascular perfusion upon exchange transfusion with stored red blood cells in normovolemic anemic conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Age of blood in inventory at a large tertiary care hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Update on transfusion medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Blood transfusion. An independent risk factor for postinjury multiple organ failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Association of mortality with age of blood transfused in septic ICU patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Effects of storage on efficacy of red cell transfusion: when is it not safe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Progress in the development of RBC substitutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Hemoglobin solutions--not just red blood cell substitutes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Clinical evaluation of heme iron polypeptide: sustaining a response to rHuEPO in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

A randomized controlled study of iron supplementation in patients treated with erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Iron, infections, and anemia of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Just the FAQs: frequently asked questions about iron and anemia in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Risk of infection with intravenous iron therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Risk of bacterial infection in patients under intravenous iron therapy: dose versus length of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Effect of intravenous iron on haemodialysis catheter microbial colonization and blood-borne infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

The safety of intravenous iron dextran in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Disorders of iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Alternatives to blood product transfusion in the critically ill: erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317].

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Efficacy and safety of epoetin alfa in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Number needed to treat and cost of recombinant human erythropoietin to avoid one transfusion-related adverse event in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

A restrictive use of both autologous donation and recombinant human erythropoietin is an efficient policy for primary total hip or knee arthroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Clinical studies of hip: An oral heme-iron product

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.10.1267

21 January 2018

Identifiers

DOI

10.1592/PHCO.28.10.1267

1 reference

19 August 2017

1 reference